Oct. 9, 2024
The American College of Radiology® (ACR®) provided comments  to the Centers for Medicare and Medicaid Services (CMS) in response to the agency’s September Request for Information (RFI) about the potential consolidation of four Medicare Administrative Contractor (MAC) jurisdictions into two jurisdictions, and to get feedback about extending MAC contracts from seven to 10 years. The College wrote against the consolidation and reiterated its position to strengthen the engagement of physicians within the coverage determination process.

MACs are private healthcare insurers awarded a geographic jurisdiction to process Medicare Part A and Part B medical claims or Durable Medical Equipment (DME) claims for people with traditional fee-for-service (FFS) Medicare. Currently, there are 12 A/B MACs and four DME MACs in the program that process Medicare FFS claims for nearly 51% of the total Medicare beneficiary population, approximately 34 million Medicare FFS beneficiaries.

If you have questions or want more information about local coverage policies and MAC activities, contact Alicia Blakey, ACR Principal Economic Analyst.

Related ACR News

  • Make America Healthy Again

    President Trump released an Executive Order (EO) establishing the "Make America Healthy Again (MAHA) Commission,” Feb. 13 to be led by the new Department of Health and Human Services Secretary Robert F. Kennedy Jr.

    Read more
  • Scope of Practice Bills Introduced At State Legislative Level

    The American College of Radiology® (ACR®) is tracking more than 58 scope of practice bills across 22 states with more expected to be considered.

    Read more
  • ACR Others Challenge MAC Position on Minimally Invasive Arthrodesis of the Sacroiliac Joint

    The American College of Radiology® (ACR®) and other medical specialty societies that use or perform interventional pain and spine procedures told three of the seven Medicare Administrative Contractors (MACs) that implementation of a new policy as written could limit access to a safe, effective and durable treatment option, potentially exacerbating healthcare disparities among Medicare patients.

    Read more